PBI logo

PBI

Pitney Bowes Inc.

$9.63
+$0.24(+2.56%)
60
Overall
80
Value
41
Tech
--
Quality
Market Cap
$1.48B
Volume
3.00M
52W Range
$6.88 - $13.11
Target Price
$14.00

Company Overview

Mkt Cap$1.48BPrice$9.63
Volume3.00MChange+2.56%
P/E Ratio-7.3Open$9.40
Revenue$2.0BPrev Close$9.39
Net Income$-203.6M52W Range$6.88 - $13.11
Div Yield0.36%Target$14.00
Overall60Value80
Quality--Technical41

No chart data available

About Pitney Bowes Inc.

Pitney Bowes Inc., operates as a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to small businesses, large enterprises, and government entities around the world. It operates through SendTech Solutions and Presort Services segments. The SendTech Solutions segment provides physical and digital shipping and mailing technology solutions, and other applications for sending, tracking and receiving of letters, parcels and flats, supplies, and maintenance services, as well as financing alternatives to finance equipment and product purchases. The Presort Services segment offers mail sortation services, which allow clients to qualify volumes of first-class mail, marketing mail, marketing mail flats, and bound printed matter for postal workshare discounts. It markets its products, solutions, and services through direct and inside sales force, global and regional partner channels, direct mailings, and digital channels. The company was formerly known as Pitney Bowes Postage Meter Company. Pitney Bowes Inc. was incorporated in 1920 and is headquartered in Stamford, Connecticut.

Sector: Industrials
Industry: Business Equipment

Latest News

Pitney Bowes Announces Cash Tender Offers for Notes

Pitney Bowes ( ($PBI) ) has provided an announcement. On November 21, 2025, Pitney Bowes announced the commencement of cash tender offers to purcha...

TipRanks Auto-Generated Newsdesk2 days ago

Paradigm Biopharmaceuticals’ AGM Resolutions Passed Successfully

TipRanks Australian Auto-Generated Newsdesk4 days ago

Paradigm Biopharmaceuticals Secures Additional Funding Through Convertible Notes

TipRanks Australian Auto-Generated Newsdesk6 days ago

Paradigm Biopharmaceuticals Issues 5 Million Convertible Notes

TipRanks Australian Auto-Generated Newsdesk6 days ago

Paradigm Biopharmaceuticals Secures Funding for Global Clinical Expansion

TipRanks Australian Auto-Generated Newsdesk6 days ago
ABCD
1SymbolPriceChangeVol
2PBI$9.63+2.6%3.00M
3
4
5
6

Get Pitney Bowes Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.